Medical Billing Outsourcing Market to Witness Soaring Growth During the Forecast Period: Grand View Research Inc.

 

Medical Billing Outsourcing Market Growth & Trends

The global medical billing outsourcing market size is projected to reach USD 25.9 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.66% from 2021 to 2028. A large amount of clinical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billing an intricate part of any clinical practice, posing significant challenges. Currently, the healthcare system is witnessing a subsequent rise in the outsourcing of clinical billing services by hospitals and physicians due to obligatory implementation of complex ICD-11 coding systems, increasing healthcare costs, and a federal mandate to implement Electronic Medical Records (EMR) to maintain reimbursement levels.

The COVID-19 pandemic has negatively affected the market. Though, the healthcare industry was trailing in embracing innovative and digital technologies to improve healthcare. The COVID-19 scenario has put an enormous burden on healthcare providers/organizations to become accustomed to the change. The recovery from the financial impact of the coronavirus pandemic could take a long time. Thus, players operating in the market need to create new policies/strategies powered by telemedicine solutions and patient-centric collections to rise above the challenges of COVID-19.   

Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effective handling of in-house billing functions. In addition, multispecialty healthcare groups are implementing consolidation requiring EHR integration and building large healthcare networks. This integration creates a need for revenue cycle management (RCM), which, in turn, demands additional expertise and trained personnel to manage the same. Thus, the consolidation of large healthcare practices is also expected to be one of the factors fueling the market growth.

Request a free sample copy or view report summary: Medical Billing Outsourcing Market Report

Medical Billing Outsourcing Market Report Highlights

• The outsourced segment accounted for the largest revenue share in 2020 and is expected to witness a high CAGR attributed to the rising preference of hospitals, physician office, and startups opting for outsourced medical billing services for hassle-free claim management at low cost
• The front-end services segment led the market in 2020. However, the middle-end services segment is expected to register the highest CAGR over the forecast period due to the growing demand for Revenue Cycle Management (RCM) services offering Electronic Health Records (EHR) software
• Hospitals, possessing higher claim volumes, accounted for the largest revenue share in the market in 2020 and is estimated to maintain the dominance even during the forecast years
• North America held the largest revenue share in 2020. It is projected to expand further as U.S. has witnessed a change in the healthcare system with the introduction of ICD-11 coding in 2019 and pressure from the government to incorporate the Electronic Medical Record (EMR) management system
• Medical billing and Revenue Cycle Management (RCM) companies such as Athenahealth, are offering successful implementation of EMR at the practice level and are expected to transform the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-billing-outsourcing-market

Medical Billing Outsourcing Market Segmentation

Grand View Research has segmented the global medical billing outsourcing market on the basis of component, service, end-use, and region:

Medical Billing Outsourcing Component Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Outsourced

Medical Billing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

• Front End
• Middle End
• Back End

Medical Billing Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Physician Office
• Others

Medical Billing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Medical Billing Outsourcing Market

• R1 RCM, Inc.
• Cerner Corporation
• Allscripts Healthcare Solutions, Inc.
• Experian Information Solutions, Inc.
• eClinicalWorks
• GE Healthcare
• Genpact
• HCL Technologies Limited
• Kareo, Inc.
• McKesson Corporation
• Quest Diagnostics
• Athenahealth Inc.
• The SSI Group, LLC.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pulmonary Arterial Hypertension Market is Likely To Touch USD 7.7 Billion by 2028: Grand View Research Inc.

 Pulmonary Arterial Hypertension Market Growth & Trends

The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2021 to 2028. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs are fueling the market growth.

The COVID-19 pandemic did not have much impact on the PAH market due to the normal demand for PAH drugs by the patients. All the market players reported positive growth rates in their year-on-year revenues from 2019 to 2020. However, the supply chains were disrupted to a certain level due to lockdowns in many nations globally. Overall, the impact was neutralized due to the continuous demand for drugs.

The cases of PAH are rising in the range of 100,000 to 200,000 per year. However, in the past few years, the occurrence of this disorder is intensifying due to the risk factors such as alcohol/tobacco consumption, HIV, sedentary lifestyle, smoking, and other idiopathic conditions.

The existence of a large geriatric population having lower levels of immunity is prone to PAH and associated diseases is a high impact-rendering factor for the growth of the PAH market over the forecast period. Though the beginning age for PAH is 45 years, it is often observed to occur in a population over 60 years of age.

Government initiatives such as the Rare Disease Act 2002 and The Orphan Drug Act (ODA) 1983 are also anticipated to support market growth. These are the two most vital acts that promote the ethical usage and distribution of orphan drugs. The development of orphan drugs is promoted by the National Organization of Rare Disorders and has a smaller market share.

Robust drug pipeline and new product combination awaiting approval or launch are anticipated to heighten the market competitiveness over the forecast period. In December 2020, Acceleron Pharma received orphan drug designation for Sotatercept from the European Commission and is available for commercial use in the European markets.

Request a free sample copy or view report summary: Pulmonary Arterial Hypertension Market Report

Pulmonary Arterial Hypertension Market Report Highlights

• By drug class, prostacyclin and prostacyclin analogs are projected to witness lucrative growth over the forecast period. The sales of these drugs are anticipated to grow sharply in the future, primarily due to the growth expected in oral prostacyclin agents
• North America dominated the PAH market with over 55.0% share in 2020. This is attributed to its supportive infrastructure for the development and distribution of high-quality therapies. In addition, the availability of reimbursement on PAH therapies support the market growth
• Asia Pacific is anticipated to expand at the fastest CAGR of 5.9% over the forecast period due to its large population base, rapid economic developments, and improving healthcare systems. Besides, the high burden of diseases such as HIV, which are responsible for the development of PAH, foster the growth of this regional market
• The market is consolidated and competitive. Players enjoy the benefit of high entry barriers to other firms due to the high price interdependency

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pulmonary-arterial-hypertension-pah-market-size-report

Pulmonary Arterial Hypertension Market Segmentation

Grand View Research has segmented the global pulmonary arterial hypertension market based on drug class and region:

Pulmonary Arterial Hypertension Drug Class Outlook (Revenue, USD Million, 2016 - 2028)

• Prostacyclin and Prostacyclin Analogs
• Soluble Guanylate Cyclase (SGC) Stimulators
• Endothelin Receptor Antagonist (ERA)
• Phosphodiesterase 5 (PDE-5)

Pulmonary Arterial Hypertension Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Pulmonary Arterial Hypertension Market

• Johnson & Johnson Services, Inc.
• United Therapeutics Corporation
• Pfizer, Inc.
• Acceleron Pharma, Inc.
• Gilead Sciences, Inc.
• Bayer AG
• GlaxoSmithKline Plc. (GSK)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Long Term Care Market Revenue is Expected to Reach USD 1.7 Trillion by 2028: Grand View Research Inc.

 Long Term Care Market Growth & Trends

The global long term care market size is expected to reach USD 1.7 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.1% from 2021 to 2028. The market is expected to grow primarily owing to the rising prevalence of target diseases, especially Alzheimer’s and dementia, among the aging population. In addition to this, increasing awareness about different long term care (LTC) facilities and the increasing medical coverage for home healthcare are likely to benefit the market growth.

According to World Population Prospects 2020, the global population aged 65 years and above was 703 million in 2020. The number of elderly people is projected to double by 2050 to reach 1.5 billion. The global share of the elderly population increased to 9% in 2020 from 6% in 1990 and is expected to rise further to 16% by 2050 with one in every six people in the world being over 65 years of age. It is expected that people turning 65 years are more likely to take some type of long term care services in the years to come. There has also been a shift towards in-home care from hospitals.

Developing economies make for lucrative markers as far as home healthcare is concerned. India, for instance, has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales, a factor that has worked in its favor. In India, Portea is one of the key market leaders in in-home healthcare. In November 2017, Portea raised USD 26.0 million in Series C funding for better home healthcare facilities.

Asia Pacific is expected to witness significant growth over the forecast period owing to the increasing rate of chronic diseases, the increasing disposable income, and the decreasing working population. For instance, in China, the one-child policy has eventually decreased the working population as compared to the older population. Industry players are continuously investing in expanding and revamping existing facilities. For instance, in February 2020, Genesis HealthCare underwent a real estate partnership with Next Healthcare Capital. The deal involved 15 skilled nursing facilities previously leased from Welltower Inc.

Request a free sample copy or view report summary: Long Term Care Market Report

Long Term Care Market Report Highlights

• The pandemic has created significant pressure on the entire healthcare system, but the most tragic impact is on the long term care facilities for both the younger and older generations in residential care programs
• In terms of service, nursing care held the largest share in 2020 owing to the presence of a large number of facilities offering nursing care, medical supervision, and round-the-clock assistance
• The home healthcare segment emerged as the second-largest service segment in 2020 owing to the increasing awareness regarding such facilities, cost savings offered by them as compared to hospital stays or nursing homes, and proactive health monitoring
• The hospice service segment is expected to witness the fastest growth over the forecast period owing to the increasing incidence rate of Alzheimer's and dementia and an increase in post-hospital care. Moreover, the coverage offered by both Medicaid and private insurers has relieved residents from out-of-pocket payments that have to be borne by them
• North America dominated the market in 2020. This is majorly attributed to the advanced medical infrastructure, awareness about the advantages of home health services, rising geriatric population, and government support. Around 13% of the people in the U.S. are 65 years or above and it is expected that by 2050, one in six Americans would be at least 65 years of age

Access Press Release@ https://www.grandviewresearch.com/press-release/global-long-term-care-market

Long Term Care Market Segmentation

Grand View Research has segmented the global long term care market based on service and region:

Long Term Care Service Outlook (Revenue, USD Billion, 2016 - 2028)

• Home Health Care
• Hospice
• Nursing Care
• Assisted Living Facilities
• Others

Long Term Care Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa

List of Key Players of Long Term Care Market

• Brookdale Senior Living, Inc.
• Sunrise Carlisle, LP
• Atria Senior Living Group
• Extendicare, Inc.
• Capital Senior Living
• Diversicare Healthcare Services Inc.
• Kindred Healthcare, Inc.
• Genesis Healthcare Corp.
• Senior Care Centers of America
• Home Instead Senior Care, Inc.
• Amedisys, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Continuous Glucose Monitoring Device Market Industry Analysis , Opportunity Assessment And Forecast Till 2028: Grand View Research Inc.

 Continuous Glucose Monitoring Device Market Growth & Trends

The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 10.1% from 2021 to 2028. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring (CGM) devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.

These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward continuous glucose monitoring (CGM) systems market growth.

Request a free sample copy or view report summary: Continuous Glucose Monitoring Device Market Report

Continuous Glucose Monitoring Device Market Report Highlights

• Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
• CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
• Sensors was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
• Asia Pacific is the leading regional continuous glucose monitoring device market, with Japan, China, and India on the forefront
• North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
• The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain
• Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-continuous-glucose-monitoring-cgm-devices-market

Continuous Glucose Monitoring Device Market Segmentation

Grand View Research has segmented the global continuous glucose monitoring device market on the basis of component, end use, and region:

CGM Devices Component Outlook (Revenue, USD Million, 2016 - 2028)

• Transmitters
• Sensors
• Receivers

CGM Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Home Care
• Others

CGM Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Continuous Glucose Monitoring Device Market

• Medtronic
• Dexcom, Inc.
• Hoffmann-La Roche Ltd.
• Abbott
• Novo Nordisk A/S
• Ypsomed
• GlySens, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Scanning Electron Microscopes Market During 2021 – 2028 to Gain Robust Traction: Grand View Research Inc.

 Scanning Electron Microscopes Market Growth & Trends

The global scanning electron microscopes market size is expected to reach USD 6.5 billion by 2028, registering a CAGR of 8.52% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for nanotechnology-based research and growing R&D innovation in application areas are anticipated to serve as key growth drivers. Rapid growth witnessed in application areas, such as semiconductors, automobiles, pharmaceuticals, and nanotechnology, globally is among the key factors responsible for the significant growth of the SEM market.

Technological advancements in SEM improves the quality control procedures of research laboratories in a wide range of industries, such as semiconductors, automobiles, and pharmaceutical manufacturing. Scanning electron microscopy plays a critical role in the imaging and elemental analysis of products. However, the advanced SEMs offer advantages, such as rapid analysis, compact size, and efficient results with higher resolution and 3D imaging. Furthermore, the COVID-19 pandemic is expected to increase the sale of SEMs.

Due to the growing prevalence of communicable diseases, the market is expected to observe substantial growth over the coming years. Market participants are entering into partnerships and collaborations to prove their technical capabilities. For instance, in November 2020, Thermo Fisher Scientific Inc. partnered with Nanoimaging Services (NIS)-a provider of Transmission Electron Microscopy (TEM) services. The partnership helped Thermo Fisher Scientific Inc. obtain better accessibility to NIS’s cryoelectron microscopy (cryoEM) technology for pharmaceutical applications and biotechnology.

Request a free sample copy or view report summary: Scanning Electron Microscopes Market Report

Scanning Electron Microscopes Market Report Highlights

• Application of SEM in life science is expected to account for a share of 24.77% by 2028 owing to the rising prevalence of chronic diseases leading to increased R&D expenditure and demand for digital microscopes in the fields of life sciences and medicine
• Asia Pacific is expected to witness the fastest CAGR from 2021 to 2028 due to the presence of world-class manufacturers in this region and increasing usage of SEM for elemental analysis and imaging
• Growing demand for advanced SEMs for the range of material research is expected to boost the market growth in Latin America, which is expected to grow at a CAGR of 8.6% over the forecast period
• Mergers & collaborations and product developments are the key strategies being undertaken by the market players
• For instance, in January 2020, ZEISS and RIKEN Innovation entered into a partnership agreement. The partnership was aimed at expediting bioengineering innovations and bringing change in healthcare

Access Press Release@ https://www.grandviewresearch.com/press-release/global-scanning-electron-microscope-market

Scanning Electron Microscopes Market Segmentation

Grand View Research has segmented the global scanning electron microscopes market on the basis of application and region:

Scanning Electron Microscope Application Outlook (Revenue, USD Million, 2016 - 2028)

• Material Science
• Nanotechnology
• Life Science
• Semiconductors
• Other Applications

Scanning Electron Microscope Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Scanning Electron Microscopes Market

• Bruker Corp.
• Danish Micro Engineering (DME)
• Thermo Fisher Scientific
• Hitachi High Technologies Corp.
• JEOL Ltd.
• Leica Microsystems
• Nanoscience Instruments, Inc.
• Nikon Corp.
• Olympus Corp.
• Carl Zeiss

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Intravenous Iron Drugs Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

 Intravenous Iron Drugs Market Growth & Trends

The global intravenous iron drugs market size is expected to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The introduction of novel formulations with expanded indications, increasing R&D activities, and rising awareness for diagnosis and treatment of anemia is expected to propel market demand over the forecast period.

The increase in the prevalence of chronic diseases, such as chronic kidney disease, cancer, inflammatory bowel diseases, diabetes, and acute and chronic infections, has been a major market driver facilitating a significant demand for intravenous iron drugs. According to the Globol can estimates, in 2020, around 19,292,789 new cases of cancer were diagnosed globally, which lead to around 9,958,133 deaths in the same year. According to the data published by the CDC, in 2019, an estimated 15% of U.S. adults, or around 37 million adults, are suffering from chronic kidney disease (CKD). The same source also stated that diabetes and high blood pressure are the major causes of CKD in adults, and CKD is more common in people aged 65 years or older. The rise in the incidence of chronic kidney disease globally, due to unhealthy lifestyles, has been a major growth factor for the market.

Furthermore, increasing approval and indication expansion of iron drugs in key markets has significantly supported market growth. In February 2021, Pharmacosmos announced that the National Medical Products Administration (NMPA) approved Monofer injection 100 mg/mL in China. Also, in February 2018, the company announced that the U.S. FDA approved Supplemental New Drug Application (sNDA) for Feraheme (ferumoxytol injection). The FDA approved the use of Feraheme by an eligible adult suffering from Iron Deficiency Anemia (IDA).

Request a free sample copy or view report summary: Intravenous Iron Drugs Market Report

Intravenous Iron Drugs Market Report Highlights

• Effects of the ongoing pandemic have also shown an estimated 14.0% to 30.0% kidney function loss among COVID-19 patients. Thus, increased the demand for iron drugs for the management of kidney disease-induced anemia in COVID-19 patients
• The Ferric Carboxymaltose segment accounted for the largest revenue share in 2020. Its high share is attributed to the high revenue generation of Ferinject/Injectafer in key markets
• The Chronic Kidney Disease (CKD) segment dominated the market in 2020. Its leading share is attributed to the increasing prevalence of CKD and the high incidence of IDA among CKD patients
• Key players are undertaking extensive strategic initiatives in the market, such as mergers and acquisitions, new product developments, and regional expansion, to address the growing demand
• North America dominated the market with the largest revenue share in 2020. The presence of major players and favorable reimbursement scenarios are facilitating the dominance of this region during the study period
• Asia Pacific is projected to witness a lucrative CAGR owing to the high prevalence of IDA in emerging economies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-intravenous-iron-drugs-market

Intravenous Iron Drugs Market Segmentation

Grand View Research has segmented the global intravenous iron drugs market on the basis of product, application, and region:

Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2016 - 2028)

• Iron Dextran
• Iron Sucrose
• Ferric Carboxymaltose
• Others

Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Cancer
• Others

Intravenous Iron Drugs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Intravenous Iron Drugs Market

• Vifor Pharma Management Ltd.
• AMAG Pharmaceuticals
• Daiichi Sankyo Company, Ltd. (American Regent. Inc.)
• Sanofi S.A.
• Pharmacosmos A/S
• Shield Therapeutics Plc
• AbbVie Inc. (Allergan Plc)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market For Circulating Tumor Cells Industry to Witness Tremendous Growth and Expansion by 2028

 

Circulating Tumor Cells Market Growth & Trends

The global circulating tumor cells market size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.7% from 2021 to 2027. Many potential applications of CTCs in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products Research organizations are engaged in endeavors aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed.

Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and enable rapid recovery owing to their non-invasive nature. Moreover, it enables minimal invasive screening of tumors before opting for complex surgical procedures, such as radiotherapy, chemotherapy, and surgical removal of tumors, thus positively impacting the adoption.

The limited applicability of these cells in rare cancers has hampered the revenue growth up to a certain extent. For instance, there is negligible evidence for the characterization of CTCs for sarcoma. Conversely, several methods are being investigated for the isolation of these cells, such as methods based on epithelial antigen-targeted antibodies, which are anticipated to help overcome these challenges in the coming years.

Request a free sample copy or view report summary: Circulating Tumor Cells Market Report

Circulating Tumor Cells Market Report Highlights

• The CTC detection and enrichment methods accounted for the largest revenue share owing to the presence of wide availability of products for CTC enrichment and isolation
• Moreover, high penetration in terms of usage of products offered under this segment has driven the segment share
• The growing application of nanomaterials in cancer management is anticipated to drive revenue for direct detection methods in the coming years
• The devices and systems segment dominated the market in terms of revenue share in 2020 over its counterpart segments including kits and reagents and blood collection tubes
• The presence of high-throughput automated systems coupled with the availability of a substantial number of systems to carry out detection of tumor cells has contributed to a large revenue share
• CTC analysis has major applications in research settings, including investigational research, drug developments, and biomarker studies. This has resulted in a segment’s large revenue share
• Currently, whole blood specimens are the key source of CTCs, thus accounting for the largest share in 2020
• Low use of bone marrow-derived cells in clinical settings has contributed to a smaller revenue share of this segment
• Other sources include CSF, spinal fluids, urine, and pleural effusion
• Easy availability of biological specimens, such as urine, is likely to accelerate adoption under this segment
• The market is fragmented in nature with the presence of well-established players, along with medium to small-sized players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-circulating-tumor-cells-market

Circulating Tumor Cells Market Segmentation

Grand View Research has segmented the global Circulating Tumor Cells market on the basis of technology, application, product, specimen, and region:

CTCs Technology Outlook (Revenue, USD Million, 2018 - 2027)

• CTC Detection & Enrichment Methods
  • Immunocapture (Label-based)
    • Positive Selection
    • Negative Selection
  • Size-based Separation (Label-free)
    • Membrane-based
    • Microfluidic-based
  • Density-based Separation (Label-free)
  • Combined Methods (Label-free)
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

CTCs Application Outlook (Revenue, USD Million, 2018 - 2027)

• Clinical/ Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer Stem Cell & Tumorogenesis Research
  • Drug/Therapy Development

CTCs Product Outlook (Revenue, USD Million, 2018 - 2027)

• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems

CTCs Specimen Outlook (Revenue, USD Million, 2018 - 2027)

• Blood
• Bone Marrow
• Other Body Fluids

CTCs Regional Outlook (Revenue, USD Million, 2018 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players of Circulating Tumor Cells (CTCs) Market

• QIAGEN
• Bio-Techne Corporation
• Precision for Medicine
• AVIVA Biosciences
• BIOCEPT, Inc.
• BioCEP Ltd.
• Fluxion Biosciences, Inc.
• Greiner Bio One International GmbH
• Ikonisys Inc.
• Miltenyi Biotec
• IVDiagnostics
• BioFluidica
• Canopus Bioscience Ltd.
• Biolidics Limited
• Creativ MicroTech, Inc.
• LungLife AI, Inc.
• Epic Sciences
• Rarecells Diagnostics
• ScreenCell
• Menarini Silicon Biosystems
• LineaRx, Inc. (Vitatex, Inc.)
• Sysmex Corporation
• STEMCELL Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Stethoscope Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Stethoscope Market Growth & Trends

The global stethoscope market size is anticipated to reach USD 826.72 million by 2028, expanding at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Growing prevalence of cardiovascular and respiratory disorders, and increasing geriatric population are driving the market. Increase in incidence of numerous cardiovascular and pulmonary diseases in several countries is anticipated to impact market growth over the forecast period. Stethoscope is widely used for heart auscultation (listening to the heart sound) during diagnosis of cardiac illness. It is also used to primarily examine the condition of phlegm in the respiratory tract.

Moreover, growing elderly population has increased the demand for the medical device for the primary diagnosis of numerous chronic health ailments. According to the CDC, people aged above 65 years are at a higher risk of developing several chronic diseases. In addition, the world population aged 60 years and above is expected to increase from 900 million in 2015 to 2 billion in 2050 from. This is expected to boost the market.

Furthermore, several government initiatives, the introduction of new products, and incorporation of new technologies by market players, are likely to boost the market during the forecast period. For instance, 3M has launched ‘Single-Patient Stethoscope’ to overcome the issues related to disposable stethoscopes such as, inadequate audibility and discomfort faced by healthcare professionals. The device helps in minimizing the risk of cross-contamination while enhancing patient care.

Request a free sample copy or view report summary: Stethoscope Market Report

Stethoscope Market Report Highlights

• In terms of revenue, the teaching type segment dominated the market in 2019. The device is widely used for teaching/training purposes and is ideal for instructors and medical students
• The electronic type segment is expected to witness the highest CAGR of 5.5% from 2020 to 2027 owing to advanced features offered by the medical device such as, electronically amplified sound quality, audio recording, and reduced background noises for improved diagnosis
• North America dominated the market with the highest revenue share in 2019 owing to the presence of well-established healthcare facilities and increasing prevalence of numerous heart and lung associated diseases
• In Latin America, the market is expected to witness the highest CAGR of 5.3% from 2020 to 2027 due to increasing healthcare expenditure in most of the countries in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stethoscope-market

Stethoscope Market Segmentation

Grand View Research has segmented the global stethoscope market on the basis of technology, sales channel, end-use, and region:

Stethoscope Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Electronic/Digital
• Smart Stethoscope
• Traditional Acoustic Stethoscope

Stethoscope Sales Channel Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Distributors
• E-commerce
• Direct Purchase

Stethoscope Technology & Sales Channel, Criss-cross Matrix (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Electronic/Digital
  • Distributors
  • E-commerce
  • Direct Purchase
• Smart Stethoscope
  • Distributors
  • E-commerce
  • Direct Purchase
• Traditional Acoustic Stethoscope
  • Distributors
  • E-commerce
  • Direct Purchase

Stethoscope End-use Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Home healthcare
• Hospitals
  • Urgent Care
  • Surgery Centers
• Standalone Clinics
  • Cardiologists
  • General Practitioners
  • Others
• Nurse Practitioners
• EMT/ First Responders
• Veterinary

Stethoscope Technology & End-use Criss-cross Matrix (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Electronic/Digital
  • Home healthcare
  • Hospitals
  • Standalone Clinics
  • Nurse Practitioners
  • EMT/ First Responders
• Smart Stethoscope
  • Home healthcare
  • Hospitals
  • Standalone Clinics
  • Nurse Practitioners
  • EMT/ First Responders
• Traditional Acoustic Stethoscope
  • Home healthcare
  • Hospitals
  • Standalone Clinics
  • Nurse Practitioners
  • EMT/ First Responders

Stethoscope Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE
  • Oman
  • Yemen

List of Key Players of Stethoscope Market

• 3M
• Medline Industries Inc.
• Welch Allyn (Hill-rom Holdings, Inc.)
• Eko Devices Inc.
• GF Health Products, Inc.
• Rudolf Riester GmbH, (Halma Plc)
• American Diagnostics Corporation
• Cardionics
• Heine Optotechnik Gmbh & Co.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Vitro Fertilization Market Set to Surge Significantly During 2021-2028: Grand View Research Inc.

 In Vitro Fertilization Market Growth & Trends

The global in vitro fertilization market size is expected to reach USD 33.9 billion by 2028, expanding at a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the continuous efforts of the market players, government initiatives for better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures, such as ICSI for treating infertility, is expected to positively impact the market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is further expected to drive the market. The insurance companies are providing coverage to IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors, such as a behavioral shift in society, a shift from rural to urban societies, increased age of first-time mothers or the age at which women give birth to their first child, an increasing number of women in the labor force, postponement of marriage, and lower marriage rates.

The in-person fertility treatments in the U.S. and Canada were suspended in March 2020 by the Canadian Fertility and Andrology Society and the American Society of Reproductive Medicine due to the COVID-19 pandemic. However, treatments are resuming in many countries with the ease of restrictions, including the developing nations. For instance, in July 2020, Medicover Fertility, an IVF center in India, announced to resume the IVF procedures after the initial COVID-19 risk assessment.

Request a free sample copy or view report summary: In Vitro Fertilization Market Report

In Vitro Fertilization Market Report Highlights

• Culture media dominated the IVF market in 2020 accounting for the maximum revenue share. Several research activities are being undertaken to improve the efficiency of culture media
• For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery & sperm-hyaluronic acid-binding
• Europe dominated the global market with the highest revenue share in 2020 due to the availability of affordable treatments, adherence to medical standards, and quick adoption of advanced technologies, such as time-lapse microscopy by the clinics in the region
• The APAC region is expected to witness an increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
• The developing countries in the APAC region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
• In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ivf-market

In Vitro Fertilization Market Segmentation

Grand View Research has segmented the global in vitro fertilization market on the basis of type, end use, instrument, and region:

IVF Type Outlook (Revenue, USD Million, 2016 - 2028)

• Fresh Non-donor
• Frozen Non-donor
• Fresh Donor
• Frozen Donor

IVF End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Fertility Clinics
• Hospitals & Others Settings

IVF Instrument Outlook (Revenue, USD Million, 2016 - 2028)

• Culture Media
• Disposable Devices
• Capital Equipment

IVF Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK.
  • Belgium
  • The Netherlands
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of In Vitro Fertilization Market

• OvaScience
• EMD Serono, Inc.
• Vitrolife AB
• Irvine Scientific
• Cook Medical, Inc.
• Cooper Surgical, Inc.
• Genea Biomedx
• Thermo Fisher Scientific, Inc.
• Progyny, Inc.
• Boston IVF

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Contract Manufacturing And Research Services Market Size Is Expected To Reach USD 276.8 Billion by 2028

     Pharmaceutical Contract Manufacturing And Research Services Market Growth & Trends

The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 276.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.75% from 2021 to 2028. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth.

The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages are set to make inroads and grow at a tremendous pace in the forecast period.

However, drug manufacturers are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth. However, the COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus towards manufacturing COVID-19 therapies and vaccines. For example, 42 contract manufacturing services have publicly disclosed for 26 unique pipeline COVID-19 vaccines that they shall manufacture. The majority of vaccine manufacturers have been seen to partner with CMOs in locations, such as the U.K., the U.S., and Germany.

Request a free sample copy or view report summary: Pharmaceutical Contract Manufacturing And Research Services Market Report

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

• By service, the manufacturing segment dominated the market in 2020. In this segment, Active Pharmaceutical Ingredient(API) / bulk drugs held the largest revenue share in 2020. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
• In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR from 2021 to 2028
• The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share in 2020 and is anticipated to maintain its lead in the coming years
• CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil. Russia, India, and China
• Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years. Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmaceutical-contract-manufacturing-contract-research-market

Pharmaceutical Contract Manufacturing And Research Services Market Segmentation

Grand View Research has segmented the global pharmaceutical contract manufacturing and research services market on the basis of service and region:

Pharmaceutical Contract Manufacturing & Research Services Outlook (Revenue, USD Billion, 2016 - 2028)

• Manufacturing
  • API/Bulk Drugs
  • Advanced Drug Delivery Formulations Packaging
  • Packaging
  • Finished Dose Formulations
    • Solid Formulations
    • Liquid Formulations
    • Semi-solid Formulations
  • Research
    • Oncology
    • Vaccines
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others

Pharmaceutical Contract Manufacturing & Research Services Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
• Asia Pacific
  • India
  • China
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Argentina
  • Chile
  • Venezuela
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Pharmaceutical Contract Manufacturing And Research Services Market

• Catalent
• Pharmaceutical Product Development LLC
• AbbVie
• Baxter BioPharma Solutions
• Patheon
• Grifols International, S.A.
• Dalton Pharma Services
• Boehringer Ingelheim Biopharmaceuticals GmbH
• Lonza AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.